IT201700093527A1 - Composition based on strains of bacteria and / or their derivatives for stimulation of the immune system topically or systemically for the treatment of viral infections such as Papilloma virus - Google Patents

Composition based on strains of bacteria and / or their derivatives for stimulation of the immune system topically or systemically for the treatment of viral infections such as Papilloma virus

Info

Publication number
IT201700093527A1
IT201700093527A1 IT102017000093527A IT201700093527A IT201700093527A1 IT 201700093527 A1 IT201700093527 A1 IT 201700093527A1 IT 102017000093527 A IT102017000093527 A IT 102017000093527A IT 201700093527 A IT201700093527 A IT 201700093527A IT 201700093527 A1 IT201700093527 A1 IT 201700093527A1
Authority
IT
Italy
Prior art keywords
systemically
topically
strains
stimulation
bacteria
Prior art date
Application number
IT102017000093527A
Other languages
Italian (it)
Inventor
Giovanni Mogna
Original Assignee
Probiotical Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Probiotical Spa filed Critical Probiotical Spa
Priority to IT102017000093527A priority Critical patent/IT201700093527A1/en
Publication of IT201700093527A1 publication Critical patent/IT201700093527A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
IT102017000093527A 2017-08-11 2017-08-11 Composition based on strains of bacteria and / or their derivatives for stimulation of the immune system topically or systemically for the treatment of viral infections such as Papilloma virus IT201700093527A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IT102017000093527A IT201700093527A1 (en) 2017-08-11 2017-08-11 Composition based on strains of bacteria and / or their derivatives for stimulation of the immune system topically or systemically for the treatment of viral infections such as Papilloma virus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102017000093527A IT201700093527A1 (en) 2017-08-11 2017-08-11 Composition based on strains of bacteria and / or their derivatives for stimulation of the immune system topically or systemically for the treatment of viral infections such as Papilloma virus

Publications (1)

Publication Number Publication Date
IT201700093527A1 true IT201700093527A1 (en) 2019-02-11

Family

ID=60991173

Family Applications (1)

Application Number Title Priority Date Filing Date
IT102017000093527A IT201700093527A1 (en) 2017-08-11 2017-08-11 Composition based on strains of bacteria and / or their derivatives for stimulation of the immune system topically or systemically for the treatment of viral infections such as Papilloma virus

Country Status (1)

Country Link
IT (1) IT201700093527A1 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2482536A (en) * 2010-08-05 2012-02-08 Hera Pharmaceuticals Inc Expression of antibody or a fragment thereof in lactobacillus
WO2015170159A1 (en) * 2014-05-05 2015-11-12 Giovanni Mogna A composition for use in treating or preventing viral or bacterial infections in a subject undergoing anti-tumor chemotherapy, leukemia treatment or aids therapy comprising l. reuteri ler03 and/or l. salivarius ls06.
US20160089429A1 (en) * 2013-04-19 2016-03-31 Bioleaders Corporation Oral vaccine having improved cellular immunity induction potency

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2482536A (en) * 2010-08-05 2012-02-08 Hera Pharmaceuticals Inc Expression of antibody or a fragment thereof in lactobacillus
US20160089429A1 (en) * 2013-04-19 2016-03-31 Bioleaders Corporation Oral vaccine having improved cellular immunity induction potency
WO2015170159A1 (en) * 2014-05-05 2015-11-12 Giovanni Mogna A composition for use in treating or preventing viral or bacterial infections in a subject undergoing anti-tumor chemotherapy, leukemia treatment or aids therapy comprising l. reuteri ler03 and/or l. salivarius ls06.

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
PEDRO RIBELLES ET AL: "Protection against human papillomavirus type 16-induced tumors in mice using non-genetically modified lactic acid bacteria displaying E7 antigen at its surface", APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, vol. 97, no. 3, 1 February 2013 (2013-02-01), DE, pages 1231 - 1239, XP055470343, ISSN: 0175-7598, DOI: 10.1007/s00253-012-4575-1 *

Similar Documents

Publication Publication Date Title
PH12017500207A1 (en) Indoles for use in influenza virus infection
CY1124663T1 (en) N4-HYDROXYCYTIDINE ANTIBIOTIC DERIVATIVES
AR125321A2 (en) CRYSTALLINE COMPOUND, METHOD OF PREPARATION AND COMPOSITION INCLUDING IT
HK1251219A1 (en) Novel 6,7-dihydropyrido[2,1-a]phthalazin-2-ones for the treatment and prophylaxis of hepatitis b virus infection
PH12017500393A1 (en) Pyrrolopyrimidines for use in influenza virus infection
WO2015153889A3 (en) Materials and methods for the treatment of latent viral infection
CL2016002179A1 (en) New 6-fused heteroaryl dihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection.
WO2016109663A3 (en) Derivatives and methods of treating hepatitis b infections
CL2015000787A1 (en) 1,2,4-Triazine derivatives for the treatment of viral infections.
CL2015001864A1 (en) Compounds derived from substituted spiropyrido [1,2-a] pyrazine, as hiv integrase inhibitors; pharmaceutical composition that includes them; and its use for the prophylaxis or treatment of a hiv infection.
CA3010327A1 (en) Aryl substituted pyrimidines for use in influenza virus infection
WO2015082570A8 (en) Cmv vaccines
CL2015002897A1 (en) Bace1 inhibitors
MX2017003928A (en) Long acting pharmaceutical compositions.
LT3400225T (en) Pentanoic acids substituted by pyrrolo-[2-3,b]pyrimidine-pyridines for the treatment of influenza viral infections
BR112018013761A2 (en) antiproliferative compounds and their pharmaceutical compositions and uses
CL2017001160A1 (en) Combination of long-acting compositions and methods for hepatitis c
CL2017001161A1 (en) Long-acting pharmaceutical compositions for hepatitis c
EA201500942A1 (en) ANTI-VIRUS INDOLO [2,3-b] HINOXALINE
IT201700093527A1 (en) Composition based on strains of bacteria and / or their derivatives for stimulation of the immune system topically or systemically for the treatment of viral infections such as Papilloma virus
WO2015018797A3 (en) Antiviral compounds
WO2016073652A8 (en) Iminosugars useful for the treatment of viral diseases
UA114828C2 (en) APPLICATION OF DECAMETOXIN AS A PHARMACEUTICAL ACTIVE SUBSTANCE FOR TREATMENT OF Gastrointestinal and Intestinal Infections Oral
UY36030A (en) "RNA PRODUCTION IN SUPERIOR PLANTS".
PL409016A1 (en) N-sulfonic derivative of polyallylamine, application of N-sulfonic derivative of polyallylamine as a medicine, preferably for the prevention and treatment of infection by influenza type A (IAV) virus and the pharmaceutical composition containing the N-sulfonic derivate of polyallylamine